Invokana can cause gangrene of the genitals, a flesh-eating genital infection sometimes known as necrotizing fasciitis or Fournier’s gangrene.
Invokana, Invokamet, Farxiga, and Jardiance – SGLT2 diabetes drugs – increase the risk of amputations. The FDA released this warning August 29, 2018:
The U.S. Food and Drug Administration (FDA) is warning that cases of a rare but serious infection of the genitals and area around the genitals have been reported with the class of type 2 diabetes medicines called sodium-glucose cotransporter-2 (SGLT2) inhibitors. This serious rare infection, called necrotizing fasciitis of the perineum, is also referred to as Fournier’s gangrene. We are requiring a new warning about this risk to be added to the prescribing information of all SGLT2 inhibitors and to the patient Medication Guide.
According to the American Diabetes Association, ketoacidosis – also known as acidosis or diabetic ketoacidosis (DKA) – causes one to produce dangerous levels of blood acids, or keytones, which can lead to diabetic coma and can be fatal. The FDA is now reviewing the safety of all SGLT2 inhibitors to determine if the risk of ketoacidosis should be noted on the drugs’ labels, and also whether Invokana raises the risk of amputations.
Goldblatt + Singer is investigating potential Invokana lawsuits on behalf of anyone hospitalized due to gangrene of the genitals, ketoacidosis, diabetic ketoacidosis (DKA), ketosis, or acidosis while using Invokana, Invokamet, Farxiga, Jardiance, or another Type 2 diabetes medication known as sodium-glucose cotransporter-2 (SGLT2) inhibitors.
If you were hospitalized with infection or gangrene of the genitals after taking Invokana or a similar diabetes medication, or if you lost a limb or limbs after taking one of these drugs, contact our legal staff today for a free consultation regarding a potential lawsuit against the drug’s maker. By filing an diabetes drug gangrene lawsuit, you may be able to obtain compensation for medical bills, lost wages, pain, suffering and other damages related to your injuries.
FDA reviewed 20 adverse event reports from people seriously injured or hospitalized after taking type 2 diabetes drugs that included Invokana and Invokamet. These drugs belong to a class of medications known as sodium-glucose cotransporter-2 (SGLT2) inhibitors. They were approved by FDA to lower blood sugar levels in adults suffering from type 2 diabetes.
The FDA announcement warned patients to seek immediate medical help for symptoms of ketoacidosis. Symptoms include several potentially serious health issues:
Goldblatt + Singer drug injury lawyers are ready to help those injured by gangrene of the genitals, or ketoacidosis after taking diabetes medication such as Invokana, Invokamet, Jardiance and others. Please call us today at (314) 888-1000.